Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

Journal Article · Sat Apr 15 04:00:00 EDT 2017 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-016-1537-5· OSTI ID:22645245

Young, Shamar; D’Souza, Donna; Flanagan, Siobhan; Golzarian, Jafar ^[1]

---

1. University of Minnesota, Department of Radiology, Division of Interventional Radiology (United States)

Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

• OSTI ID: 22645245
• Journal Information: Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 4 Vol. 40; ISSN 0174-1551; ISSN CAIRDG
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
DRUGS
LIVER
METASTASES
NEOPLASMS
PATIENTS
REVIEWS
VASCULAR DISEASES